Previous 10 | Next 10 |
Gainers: BroadVision (NASDAQ: BVSN ) +36% . Frontier Communications (NYSE: FTR ) +26% . Tandem Diabetes Care (NASDAQ: TNDM ) +26% . Sea Limited (NYSE: SE ) +25% . Realm Therapeutics Plc ( RLM ) +16% . MeiraGTx Holdings plc (NASDAQ: MGTX ) +23% . Summit Therapeutics plc (NASDAQ:...
LONDON and NEW YORK, Feb. 27, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that it has agreed to sell approximately 5.8 million ordinary shares at a price of $13.80 per share. MeiraGTx antici...
LONDON and NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the appointment of Dr. Martin Indyk to its Board of Directors. Martin Indyk is an American diplomat who...
In (yet another) statement , FDA Commission Scott Gottlieb, M.D. announces the issuance of final updated guidance for gene therapy and cell therapy developers. More news on: Abeona Therapeutics Inc., Bellicum Pharmaceuticals, ZIOPHARM Oncology, Inc., Healthcare stocks news, Read more ...
The following slide deck was published by MeiraGTx Holdings plc in conjunction with this Read more ...
Axovant Sciences Ltd ( AXON ) is approaching two key catalysts which may attract the attention of the markets. When I last wrote about the company , I noted that I didn't like the decisions being made at AXON. Throughout 2019 we may begin to see if the company's risky decision, to pivot into ...
LONDON and NEW YORK, Feb. 05, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., president and chief executive officer of MeiraGTx, will present at the BIO ...
Gainers: Fortress Biotech (NASDAQ: FBIO ) +41% . MeiraGTx Holdings (NASDAQ: MGTX ) +29% . Eldorado Gold (NYSE: EGO ) +23% . Avon Products (NYSE: AVP ) +22% . Silicom (NASDAQ: SILC ) +20% . Onconova Therapeutics (NASDAQ: ONTX ) +20% . 1-800-FLOWERS.COM (NASDAQ: FLWS ) +19% . Tu...
MeiraGTx (NASDAQ: MGTX ) inks a collaboration agreement with Johnson & Johnson (NYSE: JNJ ) unit Janssen Pharmaceutical to develop and commercialize gene therapies for the treatment of inherited retinal diseases (IRDs), including MGTX's candidates for achromatopsia (partial or total ab...
-- Conference call and webcast today, January 31, 2019 at 8:30 a.m. EST -- MeiraGTx to receive $100 million cash upfront payment upon closing -- MeiraGTx to receive 20% net sales royalties and additional potential future milestone payments -- Janssen Pharmaceuticals, Inc. to fund al...
News, Short Squeeze, Breakout and More Instantly...
MeiraGTx Holdings plc Company Name:
MGTX Stock Symbol:
NASDAQ Market:
MeiraGTx Holdings plc Website:
- Positive data from the Phase 1 AQUAx study in radiation-induced xerostomia (RIX) presented in an oral session at the American Academy of Oral Medicine 2024 annual meeting (AAOM) April 17-20, 2024 - Received $50 million milestone following initiation of the extension study for the Ph...
LONDON and NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced the Company gave an oral presentation at the American Academy of Oral Medicine Annual Conference, being held f...
2024-04-17 00:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...